A busy week this week on Twitter, so if you don’t follow us at @crossborderbio, here’s your weekend remedial reading:
- RT @mrcglobal: From the Economist: Innovation in global health – A spoonful of ingenuity http://bit.ly/7R2Lfy 1 day ago
- RT @PharmProEditor: MDS Appoints Steve West MDS Inc. CEO – Peter Dans Appointed Future CFO http://bit.ly/7LSIH5 1 day ago
- Good stuff! RT @MaRSDD RT @ttang_ Looking for funding and capital in Ontario? Here’s the cheat sheet from @marsdd http://bit.ly/7frAST 1 day ago
- RT @FierceBiotech: Biotech drugs to watch in 2010: A trio of obesity pills,cancer vaccine, insulin inhaler & MS treatment http://is.gd/5S9rr 1 day ago
- RT @InVivoBlogEllen: In the”what took him so long”? dept RT @MDBpartners @Street_Insider Icahn may launch $GENZ prxy battl http://ow.ly/TKk2 1 day ago
- RT @FDAcdrhIndustry: 510(k) Clearances for 12/09 http://bit.ly/4nFutT #fda #medicaldevice 1 day ago
- RT @AHCJ_Pia: Federal EMR budget slashed, switchover delayed? http://bit.ly/7OYols 2 days ago
- Agree! http://ow.ly/16gUQA RT @genomicslawyer via @markgfh Demand for Designer Babies.. http://bit.ly/6rR9Bo reviewing http://bit.ly/4tmn1v 2 days ago
- Haemacure Shares to be Delisted from the Toronto Stock Exchange, does not plan to appeal or move http://viigo.im/20be 2 days ago
- @scotthensley That is so much less traumatic than I expected when I read the words “blogging uniforms.” 2 days ago
- PatentlyO post has 3 lessons for tech transfer from 1 case – joint ownership, quiet title and Bayh-Dole jurisdiction http://bit.ly/8IzP2S 2 days ago
- Good stuff. RT @genomicslawyer: Five Questions for Personal Genomics in 2010: http://bit.ly/6l4JCm 2 days ago
- RT @mikesgene: Britain must launch GM food revolution, says chief scientist Environment | The Guardian… http://ga.newsi.us/?x=kw 2 days ago
- RT @CVCACanada: VC’s on the move: @rogerchabra moves from GrowthWorks Capital to Rho Canada (Rho Ventures) 2 days ago
- RT @FierceBiotech: New Enterprise Associates (one of our 2009 Top VC firms: http://is.gd/5OgER) has closed a $2.5B fund. http://is.gd/5OgJb 2 days ago
- RT @FierceBiotech: New CEO Mark Corrigan navigates CombinatoRx’s revolving door. http://is.gd/5OcOx 2 days ago
- RT @ldtimmerman: Seattle Genetics maps out a future with antibodies that are “empowered,” not naked. http://bit.ly/4RwFH2 2 days ago
- RT @genomicslawyer: Vanderbilt Opens Doors to DNA Databank http://bit.ly/4TV3mw How to rapidly grow a genetic databank? Make it “opt out” 3 days ago
- But … RT @FierceBiotech: Biotech drug approvals spiked in 2009. http://is.gd/5O2KD
- RT @PharmProEditor: #FDA Drug Approvals Mostly Flat in 2009 http://bit.ly/5sAGF6
- RT @rilescat: HHS Announces New Health IT Workforce Grants… http://bit.ly/7hbaox
- RT @IAmBiotech: Meet Mike Spear [@mikesgene], GenomeAlberta: http://ow.ly/SXnE Go, Canada!
- Next @RICCentre GYB session Jan 20 features Angel, VC and Company panelists on raising cash http://bit.ly/8PMaVi
- RT @mhuckman: #JPM10 RT @adamfeuerstein: JPMorgan H/C confab preview: http://tinyurl.com/yhbbyzv
- RT @RICCentre: Check out the post by our very own @sharon_dotan on market intelligence on the @MaRSDD blog – http://bit.ly/7tar4a
- RT @InVivoBlogEllen: RT @SternIR: In Vivo Alliance Deal of the Year: GSK/Concert; $35MM upfront for 3 Ph 1 programs. http://bit.ly/88A6uk
- RT @InVivoBlogChris: … Winners of In Vivo Blog’s 2009 Deal of the Year competition are: http://bit.ly/5Qutbm
- RT @sheffi: Social Media & Pharma talk in NYC on the 20th: http://bit.ly/6xbvvX /cc @shwen
- RT @FDA_Drug_Info: Presentations from Public Hearing–Promotion of Medical Products Using the Internet & Social Media. http://bit.ly/SM_Pres
- Nice! RT @AHCJ_Pia: RT @eyeonfda: Twitter list of Gov’t Agencies in Healthcare – http://is.gd/5LWT9
- RT @dgmacarthur: Nice Forbes piece by @matthewherper on how genetics is transforming dairy agriculture: http://bit.ly/7UCiYV
- RT @matthewherper: Eugene Braunwald in NYT on conflict of interest: “…what was O.K. three years ago is not O.K. now.” http://bit.ly/4Rg6QH

missed those last week, will follow crossborderbio on twitter as to stay updated